AstraZeneca's stomach cancer drug extends overall survival, late-stage trial data finds

AstraZeneca, Sanofi, Boehringer Back Owkin AI to Cut Drug Bottlenecks

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

AstraZeneca Signs Up For $555 Million AI Deal With Algen To Develop Therapies